193 related articles for article (PubMed ID: 23399430)
21. Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for the controlled release of capecitabine.
Agnihotri SA; Aminabhavi TM
Int J Pharm; 2006 Nov; 324(2):103-15. PubMed ID: 16824710
[TBL] [Abstract][Full Text] [Related]
22. Chitosan - Locust bean gum interpenetrating polymeric network nanocomposites for delivery of aceclofenac.
Jana S; Sen KK
Int J Biol Macromol; 2017 Sep; 102():878-884. PubMed ID: 28456644
[TBL] [Abstract][Full Text] [Related]
23. Novel alginate hydrogel core-shell systems for combination delivery of ranitidine HCl and aceclofenac.
Jana S; Samanta A; Nayak AK; Sen KK; Jana S
Int J Biol Macromol; 2015 Mar; 74():85-92. PubMed ID: 25478963
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N
AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557
[TBL] [Abstract][Full Text] [Related]
26. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats.
Onishi H; Koyama K; Sakata O; Machida Y
Drug Dev Ind Pharm; 2010 Aug; 36(8):879-84. PubMed ID: 20345284
[TBL] [Abstract][Full Text] [Related]
27. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
[TBL] [Abstract][Full Text] [Related]
28. Triamcinolone-loaded glutaraldehyde cross-linked chitosan microspheres: prolonged release approach for the treatment of rheumatoid arthritis.
Dhanaraju MD; Elizabeth S; Gunasekaran T
Drug Deliv; 2011 Apr; 18(3):198-207. PubMed ID: 21028952
[TBL] [Abstract][Full Text] [Related]
29. pH-sensitive hydrogels based on semi-interpenetrating network (semi-IPN) of chitosan and polyvinyl pyrrolidone for clarithromycin release.
Vaghani SS; Patel MM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1160-9. PubMed ID: 21417603
[TBL] [Abstract][Full Text] [Related]
30. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
[TBL] [Abstract][Full Text] [Related]
31. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery.
Zhang J; Tang Q; Xu X; Li N
Int J Pharm; 2013 May; 448(1):168-74. PubMed ID: 23524117
[TBL] [Abstract][Full Text] [Related]
33. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
Agnihotri SA; Aminabhavi TM
J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
[TBL] [Abstract][Full Text] [Related]
34. Extraction and Characterization of Tamarind (Tamarind indica L.) Seed Polysaccharides (TSP) from Three Difference Sources.
Chawananorasest K; Saengtongdee P; Kaemchantuek P
Molecules; 2016 Jun; 21(6):. PubMed ID: 27314322
[TBL] [Abstract][Full Text] [Related]
35. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery.
Mura C; Nácher A; Merino V; Merino-Sanjuán M; Manconi M; Loy G; Fadda AM; Díez-Sales O
Colloids Surf B Biointerfaces; 2012 Jun; 94():199-205. PubMed ID: 22341520
[TBL] [Abstract][Full Text] [Related]
36. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
Barakat NS; Almurshedi AS
J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S
Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
[TBL] [Abstract][Full Text] [Related]
38. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
[TBL] [Abstract][Full Text] [Related]
39. Design, characterization and in-vitro evaluation of different cellulosic acrylic and methacrylic polymers loaded aceclofenac microspheres.
Dewan I; Miah S; Islam SM; Rana S
Pak J Pharm Sci; 2014 Sep; 27(5):1241-8. PubMed ID: 25176362
[TBL] [Abstract][Full Text] [Related]
40. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
Barakat NS; Almurshedi AS
J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
